
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis
Ping Xie, Minghua Zhang, Shan He, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 191
Ping Xie, Minghua Zhang, Shan He, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 191
Showing 1-25 of 191 citing articles:
Protein neddylation: beyond cullin–RING ligases
Radoslav I. Enchev, Brenda A. Schulman, Matthias Peter
Nature Reviews Molecular Cell Biology (2014) Vol. 16, Iss. 1, pp. 30-44
Open Access | Times Cited: 509
Radoslav I. Enchev, Brenda A. Schulman, Matthias Peter
Nature Reviews Molecular Cell Biology (2014) Vol. 16, Iss. 1, pp. 30-44
Open Access | Times Cited: 509
Tunable protein synthesis by transcript isoforms in human cells
Stephen N. Floor, Jennifer A. Doudna
eLife (2016) Vol. 5
Open Access | Times Cited: 277
Stephen N. Floor, Jennifer A. Doudna
eLife (2016) Vol. 5
Open Access | Times Cited: 277
Neddylation: a novel modulator of the tumor microenvironment
Lisha Zhou, Yanyu Jiang, Qin Luo, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 201
Lisha Zhou, Yanyu Jiang, Qin Luo, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 201
An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network
Yang Li, Ping Xie, Liang Lu, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 197
Yang Li, Ping Xie, Liang Lu, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 197
Protein neddylation and its alterations in human cancers for targeted therapy
Lisha Zhou, Wenjuan Zhang, Yi Sun, et al.
Cellular Signalling (2018) Vol. 44, pp. 92-102
Open Access | Times Cited: 194
Lisha Zhou, Wenjuan Zhang, Yi Sun, et al.
Cellular Signalling (2018) Vol. 44, pp. 92-102
Open Access | Times Cited: 194
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
Yizhang Tang, Xujiang Yu, Liangrui He, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Yizhang Tang, Xujiang Yu, Liangrui He, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Regulating the human HECT E3 ligases
Jasper D. Sluimer, Ben Distel
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 17, pp. 3121-3141
Open Access | Times Cited: 130
Jasper D. Sluimer, Ben Distel
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 17, pp. 3121-3141
Open Access | Times Cited: 130
Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights
Ammad Ahmad Farooqı, Marc de la Roche, Mustafa B.A. Djamgoz, et al.
Seminars in Cancer Biology (2019) Vol. 58, pp. 65-79
Open Access | Times Cited: 129
Ammad Ahmad Farooqı, Marc de la Roche, Mustafa B.A. Djamgoz, et al.
Seminars in Cancer Biology (2019) Vol. 58, pp. 65-79
Open Access | Times Cited: 129
Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4–CHOP–DR5 Axis in Human Esophageal Cancer Cells
Ping Chen, Tao Hu, Yupei Liang, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 16, pp. 4145-4157
Open Access | Times Cited: 112
Ping Chen, Tao Hu, Yupei Liang, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 16, pp. 4145-4157
Open Access | Times Cited: 112
HECT E3 ubiquitin ligases – emerging insights into their biological roles and disease relevance
Yaya Wang, Diana Argiles-Castillo, Emma I. Kane, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 7
Open Access | Times Cited: 112
Yaya Wang, Diana Argiles-Castillo, Emma I. Kane, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 7
Open Access | Times Cited: 112
Neddylation of PTEN regulates its nuclear import and promotes tumor development
Ping Xie, Zhiqiang Peng, Yujiao Chen, et al.
Cell Research (2020) Vol. 31, Iss. 3, pp. 291-311
Open Access | Times Cited: 112
Ping Xie, Zhiqiang Peng, Yujiao Chen, et al.
Cell Research (2020) Vol. 31, Iss. 3, pp. 291-311
Open Access | Times Cited: 112
The functions and regulation of Smurfs in cancers
Lin Fu, Chun‐Ping Cui, Xueli Zhang, et al.
Seminars in Cancer Biology (2019) Vol. 67, pp. 102-116
Open Access | Times Cited: 89
Lin Fu, Chun‐Ping Cui, Xueli Zhang, et al.
Seminars in Cancer Biology (2019) Vol. 67, pp. 102-116
Open Access | Times Cited: 89
A conserved mechanism for regulating replisome disassembly in eukaryotes
Michael Jenkyn-Bedford, Morgan Jones, Yasemin Baris, et al.
Nature (2021) Vol. 600, Iss. 7890, pp. 743-747
Open Access | Times Cited: 79
Michael Jenkyn-Bedford, Morgan Jones, Yasemin Baris, et al.
Nature (2021) Vol. 600, Iss. 7890, pp. 743-747
Open Access | Times Cited: 79
Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate
Minyue Jia, Liya Lin, Hanxiao Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Minyue Jia, Liya Lin, Hanxiao Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Suppression of glioblastoma by targeting the overactivated protein neddylation pathway
Wei Hua, Chunjie Li, Zixiao Yang, et al.
Neuro-Oncology (2015) Vol. 17, Iss. 10, pp. 1333-1343
Open Access | Times Cited: 82
Wei Hua, Chunjie Li, Zixiao Yang, et al.
Neuro-Oncology (2015) Vol. 17, Iss. 10, pp. 1333-1343
Open Access | Times Cited: 82
Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases
Vinayak Vittal, Mikaela D. Stewart, Peter S. Brzović, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 35, pp. 21244-21251
Open Access | Times Cited: 80
Vinayak Vittal, Mikaela D. Stewart, Peter S. Brzović, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 35, pp. 21244-21251
Open Access | Times Cited: 80
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target
Qiang Gao, Guangyang Yu, Jie-Yi Shi, et al.
Oncotarget (2014) Vol. 5, Iss. 17, pp. 7820-7832
Open Access | Times Cited: 74
Qiang Gao, Guangyang Yu, Jie-Yi Shi, et al.
Oncotarget (2014) Vol. 5, Iss. 17, pp. 7820-7832
Open Access | Times Cited: 74
Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment
Sabine François, Benoît Usunier, Marie‐Elisabeth Forgue‐Lafitte, et al.
Stem Cells Translational Medicine (2018) Vol. 8, Iss. 3, pp. 285-300
Open Access | Times Cited: 74
Sabine François, Benoît Usunier, Marie‐Elisabeth Forgue‐Lafitte, et al.
Stem Cells Translational Medicine (2018) Vol. 8, Iss. 3, pp. 285-300
Open Access | Times Cited: 74
Regulation of cancer-related pathways by protein NEDDylation and strategies for the use of NEDD8 inhibitors in the clinic
Naima Abidi, Dimitris P. Xirodimas
Endocrine Related Cancer (2014) Vol. 22, Iss. 1, pp. T55-T70
Open Access | Times Cited: 71
Naima Abidi, Dimitris P. Xirodimas
Endocrine Related Cancer (2014) Vol. 22, Iss. 1, pp. T55-T70
Open Access | Times Cited: 71
miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer
Mingkun Jiang, Liang Shi, Chao Yang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Mingkun Jiang, Liang Shi, Chao Yang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Anticancer drug discovery by targeting cullin neddylation
Qing Yu, Yihan Jiang, Yi Sun
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 5, pp. 746-765
Open Access | Times Cited: 59
Qing Yu, Yihan Jiang, Yi Sun
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 5, pp. 746-765
Open Access | Times Cited: 59
TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Chihoko Yoshimura, Hiromi Muraoka, Hiroaki Ochiiwa, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 56
Chihoko Yoshimura, Hiromi Muraoka, Hiroaki Ochiiwa, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 56
Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs
Hiroshi Ageta, Kunihiro Tsuchida
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 24, pp. 4829-4848
Closed Access | Times Cited: 56
Hiroshi Ageta, Kunihiro Tsuchida
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 24, pp. 4829-4848
Closed Access | Times Cited: 56
Targeting neddylation E2s: a novel therapeutic strategy in cancer
Yi‐Chao Zheng, Yan-Jia Guo, Bo Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Yi‐Chao Zheng, Yan-Jia Guo, Bo Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 42